Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3791
This examiner grants 59% of resolved cases
Om Patel serves in Tech Center 3700 and Art Unit 3791. The examiner has 115 resolved cases and an allowance rate of 58.3 percent. This 58.3 percent rate suggests a moderate level of difficulty for applicants seeking a patent grant in this unit.
The interview lift is 54.4 percent, which is exceptionally high. This 54.4 percent lift indicates that interviews are a powerful tool for overcoming rejections and moving cases toward allowance. When compared to the 58.3 percent base allowance rate, the impact of an interview is nearly equal to the base probability of success, making it a critical strategic choice.
The median days to allowance is 1326. This timeline represents the typical duration for successful applications to reach a grant. Given the 54.4 percent interview lift, practitioners should prioritize early interviews to potentially shorten the 1326 day pendency and improve the 58.3 percent chance of allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18184794 | GUIDEWIRE WITH PORTIONS OF REDUCED STIFFNESS | Final Rejection | Boston Scientific Medical Device Limited |
| 18541084 | APPARATUS FOR DETECTING BIOMETRIC INFORMATION AND ELECTRONIC DEVICE | Non-Final OA | SHENZHEN GOODIX TECHNOLOGY CO., LTD. |
| 18916290 | METHODS FOR SENSING AND ANALYZING IMPACTS AND PERFORMING AN ASSESSMENT | Non-Final OA | THE CLEVELAND CLINIC FOUNDATION |
| 18501255 | VITAL SIGN OBTAINING DEVICE, NON-TRANSITORY COMPUTER READABLE STORAGE MEDIUM, AND VITAL SIGN OBTAINING SYSTEM | Final Rejection | Nihon Kohden Corporation |
| 18612072 | DECISION SUPPORT AND TREATMENT ADMINISTRATION SYSTEMS | Final Rejection | Dexcom, Inc. |
| 17559194 | BOLUS ADVISOR WITH CORRECTION BOLUSES BASED ON RISK, CARB-FREE BOLUS RECOMMENDER, AND MEAL ACKNOWLEDGEMENT | Final Rejection | Dexcom, Inc. |
| 18882297 | Instrument Delivery Devices, Systems, and Methods to Extend Through a Thrombus | Non-Final OA | Becton, Dickinson and Company |
| 18733310 | Blood Draw Syringe With Hemolysis Protection | Non-Final OA | Becton, Dickinson and Company |
| 18243759 | Introducer Housing for Blood Draw Device | Final Rejection | Becton, Dickinson and Company |
| 18215610 | PORTED CATHETERS CONFIGURED TO FACILITATE INSERTION OF BLOOD DRAW DEVICE | Final Rejection | Becton, Dickinson and Company |
| 18033967 | BLOOD COLLECTION DEVICES, SYSTEMS, AND METHODS | Final Rejection | Becton, Dickinson and Company |
| 18127934 | Device for Manually Locking an Inserted Line Draw Device to Prevent Premature Retraction | Final Rejection | Becton, Dickinson and Company |
| 18070916 | Flexible Capillary Tube with Integrated Luer Cap | Non-Final OA | Becton, Dickinson and Company |
| 17851621 | Instrument Delivery Device With Different Guidewire and Tubing Advancement Ratios | Non-Final OA | Becton, Dickinson and Company |
| 17752312 | Catheter Extension Set Having a Patency or Monitoring Instrument | Non-Final OA | Becton, Dickinson and Company |
| 18570027 | NEEDLE DEVICES WITH GRIP ADAPTORS AND RELATED METHODS | Non-Final OA | B. Braun Melsungen AG |
| 17642274 | Device and Method for Pre-Term Birth Risk Assessment | Non-Final OA | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) |
| 17271541 | OPTICAL DEVICE AND METHOD | Non-Final OA | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOL |
| 17493281 | MICROFABRICATED CORE WIRE FOR AN INTRAVASCULAR DEVICE | Non-Final OA | SCIENTIA VASCULAR, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy